Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 211

1.
2.

Performance and Cost-Effectiveness of Computed Tomography Lung Cancer Screening Scenarios in a Population-Based Setting: A Microsimulation Modeling Analysis in Ontario, Canada.

Ten Haaf K, Tammemägi MC, Bondy SJ, van der Aalst CM, Gu S, McGregor SE, Nicholas G, de Koning HJ, Paszat LF.

PLoS Med. 2017 Feb 7;14(2):e1002225. doi: 10.1371/journal.pmed.1002225. eCollection 2017 Feb.

3.

The performance of NLST screening criteria in Asian lung cancer patients.

Kumar V, Becker K, Zheng HX, Huang Y, Xu Y.

BMC Cancer. 2015 Nov 18;15:916. doi: 10.1186/s12885-015-1922-5.

4.

Improving selection criteria for lung cancer screening. The potential role of emphysema.

Sanchez-Salcedo P, Wilson DO, de-Torres JP, Weissfeld JL, Berto J, Campo A, Alcaide AB, Pueyo J, Bastarrika G, Seijo LM, Pajares MJ, Pio R, Montuenga LM, Zulueta JJ.

Am J Respir Crit Care Med. 2015 Apr 15;191(8):924-31. doi: 10.1164/rccm.201410-1848OC.

5.

Risk prediction models for selection of lung cancer screening candidates: A retrospective validation study.

Ten Haaf K, Jeon J, Tammemägi MC, Han SS, Kong CY, Plevritis SK, Feuer EJ, de Koning HJ, Steyerberg EW, Meza R.

PLoS Med. 2017 Apr 4;14(4):e1002277. doi: 10.1371/journal.pmed.1002277. eCollection 2017 Apr.

6.

Annual number of lung cancer deaths potentially avertable by screening in the United States.

Ma J, Ward EM, Smith R, Jemal A.

Cancer. 2013 Apr 1;119(7):1381-5. doi: 10.1002/cncr.27813. Epub 2013 Feb 25.

7.

Identifying high-risk individuals for lung cancer screening: Going beyond NLST criteria.

Fu M, Travier N, Martín-Sánchez JC, Martínez-Sánchez JM, Vidal C, Garcia M; LUCAPREV research group.

PLoS One. 2018 Apr 5;13(4):e0195441. doi: 10.1371/journal.pone.0195441. eCollection 2018.

8.

Baseline characteristics of participants in the randomized national lung screening trial.

National Lung Screening Trial Research Team, Aberle DR, Adams AM, Berg CD, Clapp JD, Clingan KL, Gareen IF, Lynch DA, Marcus PM, Pinsky PF.

J Natl Cancer Inst. 2010 Dec 1;102(23):1771-9. doi: 10.1093/jnci/djq434. Epub 2010 Nov 22. Erratum in: J Natl Cancer Inst. 2011 Oct 19;103(20):1560.

9.

Performance of Lung-RADS in the National Lung Screening Trial: a retrospective assessment.

Pinsky PF, Gierada DS, Black W, Munden R, Nath H, Aberle D, Kazerooni E.

Ann Intern Med. 2015 Apr 7;162(7):485-91. doi: 10.7326/M14-2086.

10.

Selecting High-Risk Individuals for Lung Cancer Screening: A Prospective Evaluation of Existing Risk Models and Eligibility Criteria in the German EPIC Cohort.

Li K, Hüsing A, Sookthai D, Bergmann M, Boeing H, Becker N, Kaaks R.

Cancer Prev Res (Phila). 2015 Sep;8(9):777-85. doi: 10.1158/1940-6207.CAPR-14-0424. Epub 2015 Jun 15.

11.

Development and Validation of Risk Models to Select Ever-Smokers for CT Lung Cancer Screening.

Katki HA, Kovalchik SA, Berg CD, Cheung LC, Chaturvedi AK.

JAMA. 2016 Jun 7;315(21):2300-11. doi: 10.1001/jama.2016.6255.

12.

Screening for lung cancer: time for large-scale screening by chest computed tomography.

Shlomi D, Ben-Avi R, Balmor GR, Onn A, Peled N.

Eur Respir J. 2014 Jul;44(1):217-38. doi: 10.1183/09031936.00164513. Epub 2014 Feb 13. Review.

13.

Benefits and harms of computed tomography lung cancer screening strategies: a comparative modeling study for the U.S. Preventive Services Task Force.

de Koning HJ, Meza R, Plevritis SK, ten Haaf K, Munshi VN, Jeon J, Erdogan SA, Kong CY, Han SS, van Rosmalen J, Choi SE, Pinsky PF, Berrington de Gonzalez A, Berg CD, Black WC, Tammemägi MC, Hazelton WD, Feuer EJ, McMahon PM.

Ann Intern Med. 2014 Mar 4;160(5):311-20. doi: 10.7326/M13-2316.

14.

Assessment of Selection Criteria for Low-Dose Lung Screening CT Among Asian Ethnic Groups in Taiwan: From Mass Screening to Specific Risk-Based Screening for Non-Smoker Lung Cancer.

Wu FZ, Huang YL, Wu CC, Tang EK, Chen CS, Mar GY, Yen Y, Wu MT.

Clin Lung Cancer. 2016 Sep;17(5):e45-e56. doi: 10.1016/j.cllc.2016.03.004. Epub 2016 Mar 30.

PMID:
27133540
15.

Evaluation of the lung cancer risks at which to screen ever- and never-smokers: screening rules applied to the PLCO and NLST cohorts.

Tammemägi MC, Church TR, Hocking WG, Silvestri GA, Kvale PA, Riley TL, Commins J, Berg CD.

PLoS Med. 2014 Dec 2;11(12):e1001764. doi: 10.1371/journal.pmed.1001764. eCollection 2014 Dec. Erratum in: PLoS Med. 2015 Jan;12(1):e1001787.

16.

Application of risk prediction models to lung cancer screening: a review.

Tammemägi MC.

J Thorac Imaging. 2015 Mar;30(2):88-100. doi: 10.1097/RTI.0000000000000142. Review.

PMID:
25692785
17.

Assessing the Generalizability of the National Lung Screening Trial: Comparison of Patients with Stage 1 Disease.

Tanner NT, Dai L, Bade BC, Gebregziabher M, Silvestri GA.

Am J Respir Crit Care Med. 2017 Sep 1;196(5):602-608. doi: 10.1164/rccm.201705-0914OC.

18.

Comorbidities, smoking status, and life expectancy among individuals eligible for lung cancer screening.

Howard DH, Richards TB, Bach PB, Kegler MC, Berg CJ.

Cancer. 2015 Dec 15;121(24):4341-7. doi: 10.1002/cncr.29677. Epub 2015 Sep 15.

19.

Evaluating efficacy of current lung cancer screening guidelines.

Nemesure B, Plank A, Reagan L, Albano D, Reiter M, Bilfinger TV.

J Med Screen. 2017 Dec;24(4):208-213. doi: 10.1177/0969141316689111. Epub 2017 Feb 15.

PMID:
28201949
20.

Participant selection for lung cancer screening by risk modelling (the Pan-Canadian Early Detection of Lung Cancer [PanCan] study): a single-arm, prospective study.

Tammemagi MC, Schmidt H, Martel S, McWilliams A, Goffin JR, Johnston MR, Nicholas G, Tremblay A, Bhatia R, Liu G, Soghrati K, Yasufuku K, Hwang DM, Laberge F, Gingras M, Pasian S, Couture C, Mayo JR, Nasute Fauerbach PV, Atkar-Khattra S, Peacock SJ, Cressman S, Ionescu D, English JC, Finley RJ, Yee J, Puksa S, Stewart L, Tsai S, Haider E, Boylan C, Cutz JC, Manos D, Xu Z, Goss GD, Seely JM, Amjadi K, Sekhon HS, Burrowes P, MacEachern P, Urbanski S, Sin DD, Tan WC, Leighl NB, Shepherd FA, Evans WK, Tsao MS, Lam S; PanCan Study Team.

Lancet Oncol. 2017 Nov;18(11):1523-1531. doi: 10.1016/S1470-2045(17)30597-1. Epub 2017 Oct 18.

PMID:
29055736

Supplemental Content

Support Center